Ultrasonography in granulomatous mastitis: diagnostic differentiation, treatment response, and prognostic value.

IF 1.7 4区 医学 Q3 MEDICINE, RESEARCH & EXPERIMENTAL
American journal of translational research Pub Date : 2025-06-15 eCollection Date: 2025-01-01 DOI:10.62347/MMDY4883
Xiaoli Feng, Honglei Zhang, Qiusheng Chang, Na Song, Qingju Li
{"title":"Ultrasonography in granulomatous mastitis: diagnostic differentiation, treatment response, and prognostic value.","authors":"Xiaoli Feng, Honglei Zhang, Qiusheng Chang, Na Song, Qingju Li","doi":"10.62347/MMDY4883","DOIUrl":null,"url":null,"abstract":"<p><strong>Objective: </strong>This study aimed to evaluate the diagnostic value of ultrasonography in distinguishing granulomatous mastitis (GM) from ductal carcinoma in situ (DCIS), and to assess its prognostic relevance in monitoring treatment response and predicting recurrence.</p><p><strong>Methods: </strong>In this retrospective study, we analyzed conventional B-mode ultrasound and contrast-enhanced ultrasound (CEUS) features in 146 patients with histologically confirmed GM and 140 with DCIS. Key comparisons included: (1) B-mode characteristics (lesion morphology, posterior acoustic features, microcalcifications, vascular patterns, etc.); (2) CEUS quantitative parameters [mean transit time (mTTI), time to peak, rise time, etc.]. Clinical treatment responses and recurrence data were also collected for GM patients.</p><p><strong>Results: </strong>GM exhibited distinct ultrasound characteristics compared to DCIS, including more frequent posterior acoustic enhancement (58.90% vs. 12.14%), absence of microcalcifications (82.19% vs. 49.29%), and a higher prevalence of marginal or mixed vascular patterns (83.02% vs. 73.34%) (all P < 0.001). On CEUS, GM demonstrated shorter mTTI but higher peak enhancement, wash-in, and wash-out rates than DCIS (all P < 0.001). Among the GM cohort, 121 of 146 patients achieved clinical cure. These cured patients had significantly lower pretreatment mTTI values (P < 0.001), and mTTI demonstrated predictive value for treatment response (area under the ROC curve = 0.765; sensitivity: 68.0%, specificity: 86.0%). During one-year follow-up, 15 of the 121 cured patients experienced recurrence (12.40%). The presence of ductal dilatation on ultrasound was associated with a higher recurrence rate.</p><p><strong>Conclusion: </strong>Ultrasound, particularly when combined with CEUS parameters, not only facilitates the differentiation of GM from DCIS but also serves as a valuable tool for evaluating treatment response and predicting recurrence in GM patients.</p>","PeriodicalId":7731,"journal":{"name":"American journal of translational research","volume":"17 6","pages":"4631-4641"},"PeriodicalIF":1.7000,"publicationDate":"2025-06-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12261162/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"American journal of translational research","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.62347/MMDY4883","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2025/1/1 0:00:00","PubModel":"eCollection","JCR":"Q3","JCRName":"MEDICINE, RESEARCH & EXPERIMENTAL","Score":null,"Total":0}
引用次数: 0

Abstract

Objective: This study aimed to evaluate the diagnostic value of ultrasonography in distinguishing granulomatous mastitis (GM) from ductal carcinoma in situ (DCIS), and to assess its prognostic relevance in monitoring treatment response and predicting recurrence.

Methods: In this retrospective study, we analyzed conventional B-mode ultrasound and contrast-enhanced ultrasound (CEUS) features in 146 patients with histologically confirmed GM and 140 with DCIS. Key comparisons included: (1) B-mode characteristics (lesion morphology, posterior acoustic features, microcalcifications, vascular patterns, etc.); (2) CEUS quantitative parameters [mean transit time (mTTI), time to peak, rise time, etc.]. Clinical treatment responses and recurrence data were also collected for GM patients.

Results: GM exhibited distinct ultrasound characteristics compared to DCIS, including more frequent posterior acoustic enhancement (58.90% vs. 12.14%), absence of microcalcifications (82.19% vs. 49.29%), and a higher prevalence of marginal or mixed vascular patterns (83.02% vs. 73.34%) (all P < 0.001). On CEUS, GM demonstrated shorter mTTI but higher peak enhancement, wash-in, and wash-out rates than DCIS (all P < 0.001). Among the GM cohort, 121 of 146 patients achieved clinical cure. These cured patients had significantly lower pretreatment mTTI values (P < 0.001), and mTTI demonstrated predictive value for treatment response (area under the ROC curve = 0.765; sensitivity: 68.0%, specificity: 86.0%). During one-year follow-up, 15 of the 121 cured patients experienced recurrence (12.40%). The presence of ductal dilatation on ultrasound was associated with a higher recurrence rate.

Conclusion: Ultrasound, particularly when combined with CEUS parameters, not only facilitates the differentiation of GM from DCIS but also serves as a valuable tool for evaluating treatment response and predicting recurrence in GM patients.

肉芽肿性乳腺炎的超声检查:诊断鉴别、治疗反应及预后价值。
目的:探讨超声对肉芽肿性乳腺炎(granulomatous mastitis, GM)与导管原位癌(ductal carcinoma in situ, DCIS)的鉴别诊断价值,并探讨超声在监测治疗效果和预测复发中的预后相关性。方法:回顾性分析146例组织学证实的GM患者和140例DCIS患者的常规b超和造影增强超声(CEUS)特征。重点比较包括:(1)b型特征(病变形态、后声学特征、微钙化、血管形态等);(2) CEUS定量参数[平均过峰时间(mTTI)、到达峰值时间、上升时间等]。还收集了GM患者的临床治疗反应和复发数据。结果:与DCIS相比,GM表现出明显的超声特征,包括更频繁的后部声学增强(58.90%对12.14%),微钙化的缺失(82.19%对49.29%),边缘或混合血管模式的患病率更高(83.02%对73.34%)(均P < 0.001)。在CEUS上,GM表现出比DCIS更短的mTTI,但更高的峰值增强、洗入和洗出率(均P < 0.001)。在GM队列中,146例患者中有121例获得临床治愈。这些治愈患者的预处理mTTI值显著降低(P < 0.001), mTTI对治疗反应具有预测价值(ROC曲线下面积= 0.765;敏感性:68.0%,特异性:86.0%)。随访1年,121例治愈患者中有15例复发(12.40%)。超声显示导管扩张与高复发率相关。结论:超声,特别是超声造影参数的结合,不仅有助于GM与DCIS的鉴别,而且是评估GM患者治疗效果和预测复发的重要工具。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
American journal of translational research
American journal of translational research ONCOLOGY-MEDICINE, RESEARCH & EXPERIMENTAL
自引率
0.00%
发文量
552
期刊介绍: Information not localized
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信